Journal of Clinical and Cellular Immunology
Open Access

Short Note on Cytotoxic T-Lymphocytes

Harry Dolstra^{* *}Correspondence: Harry Dolstra, Department of Cell Biology, RIMLS, Radboud University Medical Center, Nijmegen, The Netherlands, Email:

Author info »

Description

Cytotoxic T lymphocytes (CTL's) attack on B lymphoma cells is a binary "yes/no" procedure. CTL often fail to kill target cells after 1:1 conjugation in non-hematologic solid tumours, however. We suggest a method of "additive cytotoxicity" in which the efficient eradication of several cancer cells is mediated by the timedependent integration of sub lethal damage events supplied by multiple CTL transiting between them. Membrane pore development, nuclear envelope rupture, and DNA damage are all examples of reversible sub lethal damage. According to statistical modelling, successive hits administered with decay intervals of less than 50 minutes can distinguish between tumour cell death and survival following recovery. Sub-lethal multi-hit administration is particularly effective in interstitial tissue in live melanoma lesions in vivo, where high CTL concentrations and swarming support frequent serial CTLtumour cell interactions. This identifies CTL-mediated cytotoxicity via multi-hit delivery as a gradual and controllable process, in which increasing the amount and frequency of damage may boost immune efficacy.

A cyclic process of temporary cell–cell interaction and paracrine distribution of cytotoxic effector molecules to target cells, followed by target cell death, is used by cytotoxic T lymphocytes (CTLs) to carry out effector function. CTL and natural killer (NK) cells have the ability to connect to and assault many target cells in a row. Single CTLs can eliminate several antigenic target cells in vitro and in vivo as a result of multi-hit delivery, with estimates ranging from 1 to 20 kills per CTL each day based on bulk killing assays and mathematical modelling. Patients receiving adoptive transfer of tumor-specific TCR-engineered or chimeric antigen receptor (CAR) T cells, on the other hand, seldom see such high effectiveness of CTL-mediated serial killing. In antigenic solid tumour models in mice, where CTLs were observed to generate mostly short-lived contacts with target cells, which seldom result in direct apoptosis induction, evidence for successful serial target cell death after 1:1 pairings was also not achieved. In addition to tumour models, allo-immune responses against transplants and murine cytomegalovirusinfected cells in the mouse dermis show non-productive CTL contacts and failed target cell elimination. As a result, the physiological significance of CTL interactions that do not cause target cell death on their own is unclear.

Effective CTL effector function correlates with high local CTL density, according to preclinical and developing clinical findings. Mathematic modelling based on bulk three-dimensional (3D) killing assays has also been proposed to manage CTL density and thus kill efficacy. High CTL densities are thought to mediate efficient death through a variety of ways. CTL density is high, which allows for high contact frequencies and multiple CTL– tumour cell interactions. This could increase the chances of several CTL attacking a single target cell at the same time, as well as the risk of rare powerful CTL contacting tumour cells. Furthermore, the release of cytotoxic cytokines such as interferon (IFN) and Tumour Necrosis Factor (TNF) is linked to high-density T cell infiltration. However, it remains to be seen if individually ineffective CTL connections in solid tumours can become effective at high CTL density, and if so, by what mechanism these "ineffective" contacts contribute to target cell killing.

They use live-cell image analysis in vitro and in vivo, as well as molecular damage reporters, to investigate the types, temporal mechanisms, and thresholds of damage generated in antigenic tumour cells by "apparently ineffectual" CTL interactions. These findings suggest that unsuccessful CTL interactions cause sub lethal damage that builds up in the target cell over time until apoptosis is initiated. When CTL density is high, it causes tumour cells to die via a multi-hit process, whereas when CTL density is low, tumour cells heal sub-lethal damage and survive. The "additive cytotoxicity" mechanism explains how unsuccessful interactions become effective at high CTL density, and it can be used to increase medication success through micro environmental or immunological manipulation.

Millions of potential antigens must be recognised by the immune system. Because the human body has less than 30,000 genes, it is impossible to have one gene for each antigen. Instead, the DNA of millions of white blood cells in the bone marrow is scrambled, resulting in cells with distinct receptors that may connect to diverse antigens. Some receptors connect to tissues in the human body, preventing the body from attacking it; those self-reactive white blood cells are destroyed during thymus development, which requires iodine for development and activity.